TABLE 3

Clinical characteristics of the general population from the Swedish CArdioPulmonary bioImage Study (SCAPIS) grouped according to transfer coefficient of the lung for carbon monoxide (KCO) in relation to Global Lung Function Initiative (GLI) lower limit of normal (LLN) and SCAPIS LLN (n=15 040)

CharacteristicKCOp-value
>GLI LLN and >SCAPIS LLN (G1)>GLI LLN but <SCAPIS LLN (G2)<GLI LLN and <SCAPIS LLN (G3)G1 versus G2G1 versus G3G2 versus G3
Subjects13 573 (90.2)818 (5.4)649 (4.3)
Age years57.5±4.356.8±4.359.0±4.2
Female %51.552.956.9
Smoking habits %
 Never smokers47.931.114.0
 Former smokers37.136.735.3
 Current smokers11.630.248.8
 Missing information3.42.11.8
Cough %17.527.334.0<0.001<0.0010.009
Chronic bronchitis %4.48.313.2<0.001<0.0010.006
Sputum production %10.416.724.9<0.001<0.001<0.001
Wheeze %6.811.518.2<0.001<0.0010.001
Dyspnoea# %9.513.627.4<0.001<0.001<0.001
Sick leave due to respiratory problems %4.66.88.30.006<0.0010.359
Having reported asthma %7.87.99.50.9550.0160.359
Having reported COPD %1.02.010.30.024<0.001<0.001
Emphysema %4.313.935.9<0.001<0.001<0.001
FEV1/FVC <SCAPIS LLN %8.122.144.4<0.001<0.001<0.001
FEV1/FVC <GLI LLN %3.610.429.6<0.001<0.001<0.001

Data are presented as n, n (%) or mean±sd. COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity. #: modified Medical Research Council (mMRC) score ≥2; : based on high-resolution computed tomography (HRCT) findings.